Fausther Michel, G Lavoie Elise, Dranoff Jonathan A
Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Research Service, Central Arkansas Veterans Administration Health System, Little Rock, Arkansas, United States of America.
PLoS One. 2017 Sep 12;12(9):e0184499. doi: 10.1371/journal.pone.0184499. eCollection 2017.
Liver myofibroblasts are specialized effector cells that drive hepatic fibrosis, a hallmark process of chronic liver diseases, leading to progressive scar formation and organ failure. Liver myofibroblasts are increasingly recognized as heterogeneous with regards to their origin, phenotype, and functions. For instance, liver myofibroblasts express cell markers that are universally represented such as, ItgαV and Pdgfrβ, or restricted to a given subpopulation such as, Lrat exclusively expressed in hepatic stellate cells, and Gpm6a in mesothelial cells. To study liver myofibroblasts in vitro, we have previously generated and characterized a SV40-immortalized polyclonal rat activated portal fibroblast cell line called RGF-N2 expressing multiple mesothelin mRNA transcripts. Mesothelin, a cell-surface molecule expressed in normal mesothelial cells and overexpressed in several cancers such as, mesothelioma and cholangiocarcinoma, was recently identified as a key regulator of portal myofibroblast proliferation, and fibrosis progression in the setting of chronic cholestatic liver disease. Here, we identify novel mesothelin splice variants expressed in rat activated portal fibroblasts. RGF-N2 portal fibroblast cDNA was used as template for insertion of hemagglutinin tag consensus sequence into the complete open reading frame of rat mesothelin variant coding sequences by extension PCR. Purified amplicons were subsequently cloned into an expression vector for in vitro translation and transfection in monkey COS7 fibroblasts, before characterization of fusion proteins by immunoblot and immunofluorescence. We show that rat activated portal fibroblasts, hepatic stellate cells, and cholangiocarcinoma cells express wild-type mesothelin and additional splice variants, while mouse activated hepatic stellate cells appear to only express wild-type mesothelin. Notably, rat mesothelin splice variants differ from the wild-type isoform by their protein properties and cellular distribution in transfected COS7 fibroblasts. We conclude that mesothelin is a marker of activated murine liver myofibroblasts. Mesothelin gene expression and regulation may be critical in liver myofibroblasts functions and fibrosis progression.
肝肌成纤维细胞是驱动肝纤维化的特殊效应细胞,肝纤维化是慢性肝病的一个标志性过程,会导致进行性瘢痕形成和器官衰竭。肝肌成纤维细胞在起源、表型和功能方面越来越被认为具有异质性。例如,肝肌成纤维细胞表达普遍存在的细胞标志物,如整合素αV(ItgαV)和血小板衍生生长因子受体β(Pdgfrβ),或仅限于特定亚群的标志物,如仅在肝星状细胞中表达的视黄醇结合蛋白(Lrat),以及间皮细胞中的糖蛋白M6A(Gpm6a)。为了在体外研究肝肌成纤维细胞,我们之前建立并鉴定了一种名为RGF-N2的SV40永生化多克隆大鼠活化门静脉成纤维细胞系,该细胞系表达多种间皮素mRNA转录本。间皮素是一种在正常间皮细胞中表达且在几种癌症(如间皮瘤和胆管癌)中过表达的细胞表面分子,最近被确定为门静脉肌成纤维细胞增殖以及慢性胆汁淤积性肝病背景下纤维化进展的关键调节因子。在此,我们鉴定了在大鼠活化门静脉成纤维细胞中表达的新型间皮素剪接变体。通过延伸PCR,将RGF-N2门静脉成纤维细胞cDNA用作模板,将血凝素标签共有序列插入大鼠间皮素变体编码序列的完整开放阅读框中。随后将纯化的扩增子克隆到表达载体中,用于体外翻译并转染猴COS7成纤维细胞,然后通过免疫印迹和免疫荧光对融合蛋白进行鉴定。我们发现大鼠活化门静脉成纤维细胞、肝星状细胞和胆管癌细胞表达野生型间皮素和其他剪接变体,而小鼠活化肝星状细胞似乎仅表达野生型间皮素。值得注意的是,大鼠间皮素剪接变体在转染的COS7成纤维细胞中的蛋白质特性和细胞分布与野生型异构体不同。我们得出结论,间皮素是活化小鼠肝肌成纤维细胞的标志物。间皮素基因的表达和调控可能在肝肌成纤维细胞功能和纤维化进展中起关键作用。